The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 29 articles
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen J,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson TW,
Pan M,
Chatzizisis YS,
Banning AP,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter R,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
March 15, 2022 | 10.4244/EIJ-D-21-00766
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska J,
de Winter R,
Hamm C,
Steg P,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg P,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska J,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg P,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Interventional cardiology: review of the year 2017
Modolo R,
Miyazaki Y,
Chichareon P,
Asano T,
Collet C,
Tenekecioglu E,
Katagiri Y,
Soliman O,
Garg S,
Onuma Y,
Serruys P
April 20, 2018 | 10.4244/EIJ-D-18-00066
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial
Wykrzykowska J,
Garg S,
Onuma Y,
de Vries T,
Morel M,
Van Es G-A,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Corti R,
Eberli F,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Jüni P,
Windecker S,
Serruys P
September 30, 2011 | 10.4244/EIJV7I5A97
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
Brugaletta S,
Garcia-Garcia H,
Diletti R,
Gomez-Lara J,
Garg S,
Onuma Y,
Shin E,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Chevalier B,
McClean D,
Windecker S,
Whitbourn R,
Dorange C,
Veldhof S,
Rapoza R,
Sudhir K,
Bruining N,
Ormiston J,
Serruys P
April 20, 2011
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
Garg S,
Wykrzykowska J,
Serruys P,
de Vries T,
Buszman P,
Trznadel S,
Linke A,
Lenk K,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
Tyczynski P,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
March 21, 2011
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G,
Garg S,
Gomez-Lara J,
Garcia-Garcia H,
Ligthart J,
Bruining N,
Onuma Y,
Witberg K,
van Geuns R,
de Boer S,
Wykrzykowska J,
Schultz C,
Duckers H,
Regar E,
de Jaegere P,
de Feyter P,
Van Es G-A,
Boersma E,
van der Giessen WJ,
Serruys P
March 21, 2011
Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)
Legrand V,
Garg S,
Serruys P,
Virtanen K,
Szurawitzki G,
Voudris V,
Fontanelli A,
Endersen K,
Kranjec I,
Rademaker T,
Stefanadis C,
Wittebols K
February 21, 2011
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022